Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
Mark D. Schwartz(New York University), Lesley G. King(Georgetown University), Rachel Nusbaum(Icahn School of Medicine at Mount Sinai), Marie Wood(University of Colorado Cancer Center), Patti Vegella(Georgetown University), Jeanne S. Mandelblatt(Georgetown University), Yao-Jen Chang(Taipei Tzu Chi Hospital), Sarah A. Kelleher(Icahn School of Medicine at Mount Sinai), George Luta(Georgetown University), Wendy McKinnon(University of Vermont), Shelley R. McCormick(Georgetown University), Angie Tong(Georgetown University), Claudine Isaacs(Georgetown University), Kristi D. Graves(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), An‐Tsun Huang(Georgetown University), Anita Y. Kinney(Georgetown University), Beth N. Peshkin(Georgetown University), Kara-Grace Leventhal(Georgetown University), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 253
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k